Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis Bladder Pain Syndrome Pathophysiology and potential multimodal therapeutic strategies for IC BPS Nature Reviews Urology BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts Risk Classification for Interstitial Cystitis Bladder Pain Syndrome Using Machine Learning Based Predictions Urology